I will be participating in Wheel to Survive, a 6 hour indoor cycling event, to raise money for The Clearity Foundation, which helps ovarian cancer patients and their physicians make better-informed treatment decisions based on the molecular profile of the tumors.

Ovarian Cancer

Ovarian cancer is the most lethal gynecological cancer affecting 1 in 70 women.  Today more than 70% of ovarian cancer patients will die of their disease, compared to less than 20% of breast cancer patients.  When ovarian cancer is detected and treated early, the five year survival rate is greater than 92%.  Sadly though, symptoms are vague and subtle, so most patients are diagnosed at later stages and less than 50% will survive longer than 5 years after their diagnosis.

The Clearity Foundation

The Clearity Foundation, a 501 (c)(3) organization, supports women battling ovarian cancer by providing personalized information to individualize treatment decisions.  By providing tumor blueprints to patients, Clearity is bringing the future of cancer treatments to women who need help today.

Wheel to Survive Fundraising

Wheel to Survive fundraising is a 6-hour indoor cycling event sponsored by the Be The Difference Foundation.  Be The Difference Foundation mission is to help women increase their chance of survival of ovarian cancer.

How You Can Help

I truly appreciate any support you can provide.  It will benefit a great cause.   You can also help me reach my goal by sharing this page on Facebook and Twitter.  Or, send an e-mail to friends you think might be interested in contributing and include a link to my page.  Sign up and ride with me.  Thank you for your generous support and joining me to Be the Difference in the fight against ovarian cancer.  Our mothers, daughters, sisters, grandmothers and girlfriends are counting on us.

Colabrativ, Inc.’s Clinical Entry and Operations Application

For the past two years, Colabrativ, Inc. has been working with The Clearity Foundation to build a custom enterprise application to store and manage the clinical information gathered while profiling a patient's tumor.  The application, Clinical Entry and Operations (Cleo) was put into production on October 30, 2012.  More information on Cleo is available by viewing my blogs on The Clearity Foundation is in Production with Colabrativ’s Clinical Entry and Operations and Cleo (Clinical Entry and Operations) Version 2 Released.  The Clearity Foundation staff logs about five hours of work for each patient they profile.  Our goal is to lower the number of hours per patient, so that the foundation can help more patients.

I appreciate your support,
Marc Whitlow, Ph.D.
President and CEO
Colabrativ, Inc.